Voloridge Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-112,137
| Closed | -$2.72M | – | 1197 |
|
|
2025
Q1 | $2.72M | Sell |
112,137
-419,699
| -79% | -$10.2M | 0.01% | 911 |
|
|
2024
Q4 | $11.1M | Sell |
531,836
-235,393
| -31% | -$4.91M | 0.04% | 540 |
|
|
2024
Q3 | $15.3M | Buy |
767,229
+12,504
| +2% | +$249K | 0.06% | 451 |
|
|
2024
Q2 | $11.7M | Sell |
754,725
-328,312
| -30% | -$5.09M | 0.04% | 528 |
|
|
2024
Q1 | $17.3M | Buy |
1,083,037
+453,665
| +72% | +$7.23M | 0.06% | 365 |
|
|
2023
Q4 | $10.6M | Buy |
629,372
+229,213
| +57% | +$3.85M | 0.04% | 463 |
|
|
2023
Q3 | $4.68M | Buy |
400,159
+183,820
| +85% | +$2.15M | 0.02% | 682 |
|
|
2023
Q2 | $2.91M | Sell |
216,339
-286,589
| -57% | -$3.85M | 0.01% | 867 |
|
|
2023
Q1 | $8.34M | Sell |
502,928
-3,568
| -0.7% | -$59.2K | 0.04% | 505 |
|
|
2022
Q4 | $9.42M | Sell |
506,496
-210,250
| -29% | -$3.91M | 0.05% | 451 |
|
|
2022
Q3 | $9.2M | Buy |
+716,746
| New | +$9.2M | 0.05% | 466 |
|
|
2020
Q2 | – | Sell |
-128,039
| Closed | -$493K | – | 1292 |
|
|
2020
Q1 | $493K | Sell |
128,039
-156,559
| -55% | -$603K | 0.01% | 717 |
|
|
2019
Q4 | $1.07M | Buy |
284,598
+267,101
| +1,527% | +$1M | 0.02% | 634 |
|
|
2019
Q3 | $93K | Buy |
+17,497
| New | +$93K | ﹤0.01% | 1019 |
|